Presseinformationen weltweit an Journalisten und Leser verbreiten
Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its acquisition of Neomed s.r.o., a Czech Distribution company of pharmaceuticals, medical devices, and cosmetics. As part of a succession solution, Mehr
Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewopharma will be the new market authorisation holder for the drug and assuming all responsibilities of the former distributor Bristol Myers Squibb. Amikacin Mehr
Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewopharma will be the new market authorisation holder for the drug and assuming all responsibilities of the former distributor Bristol Myers Squibb. Amikacin Mehr
Getting 60 years in 2019 Ewopharma decided for a new appearance. The adjustments that have been made are a cautious and contemporary development – an evolution not a revolution. The new corporate design coincides with Ewopharma’s expanding role as the trusted Mehr